Lanean...
Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
BACKGROUND: Vonoprazan is a novel potassium‐competitive acid blocker which may provide clinical benefit in acid‐related disorders. AIM: To verify the non‐inferiority of vonoprazan vs. lansoprazole in patients with erosive oesophagitis (EE), and to establish its long‐term safety and efficacy as maint...
Gorde:
| Argitaratua izan da: | Aliment Pharmacol Ther |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4738414/ https://ncbi.nlm.nih.gov/pubmed/26559637 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13461 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|